M Farinotti
Overview
Explore the profile of M Farinotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simonetti G, Silvani A, Tramacere I, Farinotti M, Legnani F, Pinzi V, et al.
Clin Neurol Neurosurg
. 2021 Jul;
207:106808.
PMID: 34293659
Introduction: Meningiomas are usually considered benign lesions, however a proportion of them shows a more aggressive behavior, defined high-grade meningiomas (HGM). Effective medical treatments are lacking, especially at the time...
2.
Cuccarini V, Erbetta A, Farinotti M, Cuppini L, Ghielmetti F, Pollo B, et al.
J Neurooncol
. 2015 Oct;
126(2):279-88.
PMID: 26468137
MRI grading of grade II and III gliomas may have an important impact on treatment decisions. Occasionally,both conventional MRI (cMRI) and histology fail to clearly establish the tumour grade. Three...
3.
Fariselli L, Pinzi V, Milanesi I, Silvani A, Marchetti M, Farinotti M, et al.
Strahlenther Onkol
. 2013 Apr;
189(6):456-61.
PMID: 23625362
Background: The incidence of glioblastoma (GBM) in the elderly population is currently increasing, with a peak seen between 65 and 84 years. The optimal treatment in terms of both efficacy...
4.
Pedotti R, Farinotti M, Falcone C, Borgonovo L, Confalonieri P, Campanella A, et al.
Mult Scler
. 2009 Aug;
15(8):899-906.
PMID: 19667018
Background: Epidemiological studies on the association between allergic disorders, T-helper type 2 (Th2) mediated, and multiple sclerosis (MS), a T-helper type 1 (Th1)/Th17-mediated disease, provided conflicting results. Objective: The aim...
5.
Farinotti M, Simi S, Di Pietrantonj C, McDowell N, Brait L, Lupo D, et al.
Cochrane Database Syst Rev
. 2007 Jan;
(1):CD004192.
PMID: 17253500
Background: Clinical and experimental data suggest that certain dietary regimens, particularly those including polyunsaturated fatty acids (PUFAs) and vitamins might improve outcomes in people with multiple sclerosis (MS). Diets and...
6.
Filippini G, Farinotti M, Ferrarini M
Paediatr Perinat Epidemiol
. 2000 Mar;
14(1):78-84.
PMID: 10703038
The effects of maternal active and passive smoking during pregnancy on childhood central nervous system (CNS) tumours were assessed in a population-based case-control study. The mothers of 244 children aged...
7.
Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbieri E, et al.
J Neurol Neurosurg Psychiatry
. 1999 Jul;
67(2):158-62.
PMID: 10406981
Objectives: Health related quality of life (HRQOL) inventories are multi-dimensional measures of patient-centred health status developed for clinical research. The MS quality of life 54 (MSQOL-54) is an MS-specific HRQOL...
8.
Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L, et al.
Neurology
. 1999 Jan;
52(1):57-62.
PMID: 9921849
Background: Although physical rehabilitation is commonly administered to MS patients, its efficacy has not been established. Objective: We assessed the efficacy of an inpatient physical rehabilitation program on impairment, disability,...
9.
Fedrizzi E, Anderloni A, Bono R, Bova S, Farinotti M, Inverno M, et al.
Dev Med Child Neurol
. 1998 Dec;
40(10):682-8.
PMID: 9851237
The visual-motor behaviour of 15 preterm diplegic children and 50 control children (age range 4 to 7 years) was recorded on video as they performed a visual-perceptual task (an adaptation...
10.
Farinotti M, Ferrarini M, Solari A, Filippini G
Brain
. 1998 Aug;
121 ( Pt 8):1429-36.
PMID: 9712005
Incidence rates for CNS tumours in children of age 0-14 years in the Region of Lombardy, Italy, during the period 1988-93 were analysed; survival probability updated to December 1995 was...